1. Can the risk of gout with diuretic therapy be minimised?

   Newsletter Article 30 January 2013 Pages: 1 - 1

2. Hydrochlorothiazide-induced acute allergic interstitial pneumonitis is rare but potentially fatal

   Newsletter Article 30 January 2013 Pages: 1 - 1

3. Avoid benzodiazepines in chronic pain management

   Newsletter Article 30 January 2013 Pages: 2 - 2

4. Clozapine use in schizophrenia is limited by adverse effects

   Newsletter Article 30 January 2013 Pages: 2 - 3

5. ‘Sandoglobulin’ has proved to be safe but we should not be complacent

   Newsletter Article 30 January 2013 Pages: 3 - 3

6. The potential for interactions between antihypertensives and NSAIDs is great

   Newsletter Article 30 January 2013 Pages: 3 - 4

7. ACE inhibitors

   Newsletter Article 30 January 2013 Pages: 4 - 4

8. Amiodarone

   Newsletter Article 30 January 2013 Pages: 5 - 5

9. Amitriptyline/lithium

   Newsletter Article 30 January 2013 Pages: 5 - 5

10. Antineoplastics

    Newsletter Article 30 January 2013 Pages: 5 - 5

11. Antipsychotics

    Newsletter Article 30 January 2013 Pages: 5 - 5

12. Azathioprine

    Newsletter Article 30 January 2013 Pages: 5 - 5

13. Bromocriptine

    Newsletter Article 30 January 2013 Pages: 5 - 5

14. Budesonide

    Newsletter Article 30 January 2013 Pages: 6 - 6

15. Carbamazepine/clomipramine

    Newsletter Article 30 January 2013 Pages: 6 - 6

16. Chloral hydrate interaction

    Newsletter Article 30 January 2013 Pages: 6 - 6

17. Cisplatin

    Newsletter Article 30 January 2013 Pages: 6 - 6

18. Clomipramine see Carbamazepine/clomipramine

    Newsletter Article 30 January 2013 Pages: 6 - 6

19. Cocaine abuse

    Newsletter Article 30 January 2013 Pages: 6 - 6

20. Corticosteroids

    Newsletter Article 30 January 2013 Pages: 6 - 6

21. Cyclophosphamide

    Newsletter Article 30 January 2013 Pages: 6 - 7

22. Cyclosporin

    Newsletter Article 30 January 2013 Pages: 7 - 7

23. Diazepam withdrawal

    Newsletter Article 30 January 2013 Pages: 7 - 7

24. Diclofenac

    Newsletter Article 30 January 2013 Pages: 7 - 7

25. Disulfiram

    Newsletter Article 30 January 2013 Pages: 7 - 7

26. Erythromycin

    Newsletter Article 30 January 2013 Pages: 7 - 7

27. Fluoxetine

    Newsletter Article 30 January 2013 Pages: 7 - 7

28. Fluoxetine see Tricyclic antidepressants interaction

    Newsletter Article 30 January 2013 Pages: 8 - 8

29. Furosemide

    Newsletter Article 30 January 2013 Pages: 8 - 8

30. Furosemide see Chloral hydrate interaction

    Newsletter Article 30 January 2013 Pages: 8 - 8

31. Glafenine

    Newsletter Article 30 January 2013 Pages: 8 - 8

32. Glipizide

    Newsletter Article 30 January 2013 Pages: 8 - 8

33. Gonadorelin

    Newsletter Article 30 January 2013 Pages: 8 - 8

34. Labetalol

    Newsletter Article 30 January 2013 Pages: 8 - 8

35. Lindane

    Newsletter Article 30 January 2013 Pages: 8 - 8

36. Lithium see Amitriptyline/lithium

    Newsletter Article 30 January 2013 Pages: 8 - 8

37. Methotrexate

    Newsletter Article 30 January 2013 Pages: 9 - 9

38. Methotrexate interaction

    Newsletter Article 30 January 2013 Pages: 9 - 10

39. Moxisylyte

    Newsletter Article 30 January 2013 Pages: 10 - 10

40. Nitroglycerin

    Newsletter Article 30 January 2013 Pages: 10 - 10

41. NSAIDs

    Newsletter Article 30 January 2013 Pages: 10 - 10

42. Orgotein

    Newsletter Article 30 January 2013 Pages: 10 - 10

43. Pentamidine

    Newsletter Article 30 January 2013 Pages: 10 - 10

44. Phenelzine

    Newsletter Article 30 January 2013 Pages: 10 - 11

45. Phenylephrine

    Newsletter Article 30 January 2013 Pages: 11 - 11

46. Phenytoin

    Newsletter Article 30 January 2013 Pages: 11 - 11

47. Prednicarbate

    Newsletter Article 30 January 2013 Pages: 11 - 11

48. Probenecid see Methotrexate interaction

    Newsletter Article 30 January 2013 Pages: 11 - 11

49. Quinolones

    Newsletter Article 30 January 2013 Pages: 11 - 11

50. Ranitidine

    Newsletter Article 30 January 2013 Pages: 11 - 11